Notably, the major constitutive source of CXCL12 in solid tumors is factually stromal cells, including peritoneum mesothelial cells, vascular endothelial cells (VECs), and particularly cancer‐associated fibroblasts (CAFs) 17, 21. This evidence concerns the gene CXCL12 and cancer.